NeuroPace NPCE
NASDAQ NPCE
$14.50 -0.26 (-1.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

NeuroPace (NPCE) Share-based Compensation (2020 - 2026)

NeuroPace (NPCE) posted Share-based Compensation of $2.3 million for Q2 2026, up 1.1% on a QoQ basis from $2.3 million in Q1 2026, and down 28.66% year-over-year from $3.2 million in Q2 2025.

Analysis

NeuroPace (NPCE) Share-based Compensation (2020 - 2026) Analysis & Trends

NeuroPace has reported Share-based Compensation for 7 years, with the latest figure at $2.3 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation fell 28.66% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $9.8 million, a 11.15% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, up 7.85% from the prior year.
  • Share-based Compensation was $2.3 million for Q2 2026 at NeuroPace, up from $2.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $6.5 million in Q3 2022, with the low at $115000.0 in Q4 2022.
  • Average Share-based Compensation over 5 years is $2.6 million, with a median of $2.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation slumped 93.87% in 2022, then jumped 1949.57% in 2023.
  • Over 5 years, Share-based Compensation stood at $115000.0 in 2022, then surged by 1949.57% to $2.4 million in 2023, then gained by 10.44% to $2.6 million in 2024, then rose by 0.15% to $2.6 million in 2025, then declined by 11.66% to $2.3 million in 2026.
  • The last three Share-based Compensation figures came in at $2.3 million (Q2 2026), $2.3 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 168.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 67.10 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 125.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 7.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 61.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 42.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 42.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 39.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 12.80 Mn
10 NeuroPace 493.15 Mn 441.45 Mn 18.91 Mn 2.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.30 Mn
Mar 31, 2026 2.28 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 2.63 Mn
Jun 30, 2025 3.23 Mn
Mar 31, 2025 2.63 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 2.59 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 2.54 Mn
Dec 31, 2023 2.36 Mn
Sep 30, 2023 2.42 Mn
Jun 30, 2023 2.66 Mn
Mar 31, 2023 2.13 Mn
Dec 31, 2022 115,000.00
Sep 30, 2022 6.49 Mn
Jun 30, 2022 2.60 Mn
Mar 31, 2022 1.49 Mn
Dec 31, 2021 1.88 Mn
Sep 30, 2021 1.11 Mn